Floyd DM - Search Results

1

1-Benzazepin-2-one calcium channel blockers--VI. Receptor-binding model and possible relationship to desmethoxyverapamil.

Kimball SD, Hunt JT, Barrish JC, Das J, Floyd DM, Lago MW, Lee VG, Spergel SH, Moreland S, Hedberg SA, et al. Kimball SD, et al. Among authors: floyd dm. Bioorg Med Chem. 1993 Oct;1(4):285-307. doi: 10.1016/s0968-0896(00)82134-3. Bioorg Med Chem. 1993. PMID: 8081860

2

Site-specific biotinylation. A novel approach and its application to endothelin-1 analogs and PTH-analog.

Natarajan S, Festin SM, Hedberg A, Liu EC, Floyd DM, Hunt JT. Natarajan S, et al. Among authors: floyd dm. Int J Pept Protein Res. 1992 Dec;40(6):567-74. Int J Pept Protein Res. 1992. PMID: 1286942

3

Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site.

Kimball SD, Floyd DM, Das J, Hunt JT, Krapcho J, Rovnyak G, Duff KJ, Lee VG, Moquin RV, Turk CF, et al. Kimball SD, et al. Among authors: floyd dm. J Med Chem. 1992 Feb 21;35(4):780-93. doi: 10.1021/jm00082a020. J Med Chem. 1992. PMID: 1311765

4

Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.

Floyd DM, Kimball SD, Krapcho J, Das J, Turk CF, Moquin RV, Lago MW, Duff KJ, Lee VG, White RE, et al. Floyd DM, et al. J Med Chem. 1992 Feb 21;35(4):756-72. doi: 10.1021/jm00082a018. J Med Chem. 1992. PMID: 1542102

5

Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinones.

Das J, Floyd DM, Kimball SD, Duff KJ, Vu TC, Lago MW, Moquin RV, Lee VG, Gougoutas JZ, Malley MF, et al. Das J, et al. Among authors: floyd dm. J Med Chem. 1992 Feb 21;35(4):773-80. doi: 10.1021/jm00082a019. J Med Chem. 1992. PMID: 1542103

6

Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents.

Das J, Floyd DM, Kimball SD, Duff KJ, Lago MW, Krapcho J, White RE, Ridgewell RE, Obermeier MT, Moreland S, et al. Das J, et al. Among authors: floyd dm. J Med Chem. 1992 Jul 10;35(14):2610-7. doi: 10.1021/jm00092a011. J Med Chem. 1992. PMID: 1635059

7

Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.

Atwal KS, Swanson BN, Unger SE, Floyd DM, Moreland S, Hedberg A, O'Reilly BC. Atwal KS, et al. Among authors: floyd dm. J Med Chem. 1991 Feb;34(2):806-11. doi: 10.1021/jm00106a048. J Med Chem. 1991. PMID: 1995904

8

Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.

Atwal KS, Rovnyak GC, Schwartz J, Moreland S, Hedberg A, Gougoutas JZ, Malley MF, Floyd DM. Atwal KS, et al. Among authors: floyd dm. J Med Chem. 1990 May;33(5):1510-5. doi: 10.1021/jm00167a035. J Med Chem. 1990. PMID: 2329573

9

Dihydropyrimidine calcium channel blockers. 2. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.

Atwal KS, Rovnyak GC, Kimball SD, Floyd DM, Moreland S, Swanson BN, Gougoutas JZ, Schwartz J, Smillie KM, Malley MF. Atwal KS, et al. Among authors: floyd dm. J Med Chem. 1990 Sep;33(9):2629-35. doi: 10.1021/jm00171a044. J Med Chem. 1990. PMID: 2391701

10

Minimum requirements for inhibition of smooth-muscle myosin light-chain kinase by synthetic peptides.

Hunt JT, Floyd DM, Lee VG, Little DK, Moreland S. Hunt JT, et al. Among authors: floyd dm. Biochem J. 1989 Jan 1;257(1):73-8. doi: 10.1042/bj2570073. Biochem J. 1989. PMID: 2920029 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters